New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
16:30 EDTCWH, ZGNX, PZZA, GWRE, AH, AAPLOn The Fly: Closing Wrap
Stocks on Wall Street were higher after pending home sales data lifted the averages. The averages reversed off their early session lows quickly and the upward momentum carried on throughout the day, leading to a close near multi-year highs for the Dow and the S&P... ECONOMIC EVENTS: In the U.S., durable goods orders fell 5.2% in January, versus the expected decline of 4.8%. When transportation items are removed from the data, orders were up 1.9%, versus an expected increase of 0.2%. Pending home sales increased 4.5% in January from the prior month, versus an expected increase of 1.9%... COMPANY NEWS: Apple (AAPL) held its annual shareholders meeting amidst speculation that the company may announce measures to address its considerable cash holdings. However, CEO Tim Cook went no further than saying the company is having "very, very active" talks regarding what to do with its cash. Apple shares bounced around during the meeting, ending the day down $4.40, or 0.98%, at $444.57... MAJOR MOVERS: Among notable gainers was Guidewire (GWRE), up $5.22, or 16.56%, to $36.75 after the company reported earnings that beat estimates and Pacific Crest raised its price target on shares to $40 from $36. Also higher were shares of Zogenix (ZGNX), up 49c, or 40.5%, to $1.70 after the company said it is unlikely to receive an action letter from the FDA, which analysts said could be a positive. Among noteworthy losers was Accretive Health (AH), down $2.54, or 20.97%, to $9.57 after postponing its Q4 earnings report due to an accounting review. Also lower were shares of Papa John's (PZZA), down $5.18, or 9.14%, to $51.47 after the company disclosed last night that it was restating its FY09, FY10, and FY11 earnings after reassessing the accounting of its joint venture agreements. Another decliner was CommonWealth REIT (CWH), down $1.89, or 7.75%, to $22.51 as the company reiterated its intention to pursue a common share offering. Investors Corvex and Related, which yesterday said they were prepared to offer $25 per share for the company, are now reportedly ready to offer $27 per share if the planned offering is canceled and the company agrees to hold talks... INDICES: The Dow was up 175.24, or 1.26%, to 14,075.37; the Nasdaq was up 32.61, or 1.04%, to 3,162.26; and the S&P 500 was up 19.05, or 1.27%, to 1,515.99.
News For AAPL;GWRE;ZGNX;AH;PZZA;CWH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
January 13, 2015
10:59 EDTAAPLApple rises after Credit Suisse, Canaccord hike iPhone estimates
Shares of Apple (AAPL) are climbing after two research firms issued upbeat notes on the company in notes to investors today. WHAT'S NEW: Credit Suisse analyst Kulbinder Garcha upgraded Apple to Outperform from Market Perform. The company should sell 215M iPhones in both fiscal 2015 and fiscal 2016, Garcha estimated. Meanwhile, Apple's gross margins are being boosted by the increased popularity of both its 64 GB memory phones and of the IPhone 6 Plus, the analyst stated. Garcha increased his earnings per share estimate for the iPhone maker by 18% in fiscal 2015 and 20% in fiscal 2016. Additionally, the firm believes excessive net cash levels indicate a new $200B return program should occur. The analyst thinks the shares can reach $130 at least. After analyzing surveys in the U.S. that took place in December and into January, Canaccord analyst T. Michael Walkley said the surveys showed strong demand and market share gains for the new iPhones. The analyst increased his iPhone estimates for Apple's December quarter, as well as his estimates for the company's overall December quarter results. The increases were based on the positive demand trends, particularly for models with higher memory levels and prices, Walkley stated. He expects these positive trends to continue and reiterated a $135 price target and Buy rating on the shares. PRICE ACTION: In mid-morning trading, Apple climbed $3.39, or 3.1%, to $112.64.
10:00 EDTAAPLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:36 EDTAAPLActive equity options trading
Active equity options trading according to Track Data: AAPL AMD AA TWTR GILD C CELG TSLA GOOG
09:07 EDTAAPLOn The Fly: Pre-market Movers
HIGHER: Apple (AAPL), up 1.4% after Credit Suisse upgraded Apple to Outperform and raised its iPhone volume estimates again... Best Buy (BBY), up 2.8% after being upgraded to Buy from Neutral at Goldman... SunPower (SPWR), up 2.6% after being upgraded to Outperform at Credit Suisse... Alcoa (AA), up 2% after Q4 results beat expectations. RISING AFTER GUIDANCE: Pharmacyclics (PCYC), up 17.5%... CTI BioPharma (CTIC), up 8.3%... Emulex (ELX), up 15.5%... ARIAD (ARIA), up 2.6%. LOWER: ChannelAdvisor (ECOM), down 42% following preliminary fourth quarter revenue guidance and after receiving multiple analyst downgrades... Antares Pharma (ATRS), down 7.7% after the FDA recommended that the company create a larger safety database for its clinical development program for QuickShot Testosterone.
09:02 EDTPZZAPapa John's announces 2015 U.S. development incentive program
To support the continuing strong interest in new restaurant development, Papa Johnís International announced the 2015 U.S. Development Incentive Program for new and existing franchisees effective January 2015. New and existing franchisees who sign a new Development Agreement during 2015 can receive industry-leading incentives including: no franchise fee, a set of Middleby-Marshall WOW ovens and reduced royalties for four years. The program is generally available for new restaurants in the contiguous United States with a development agreement signed on or before December 27, 2015. The incentives are subject to the complete rules and eligibility requirements of the program at the time of signing a development agreement.
07:47 EDTGWREUBS to hold investor trip
Subscribe for More Information
07:36 EDTAAPLApple survey suggests demand remains strong, says Canaccord
Subscribe for More Information
07:18 EDTAAPLQuanta ramps up production of 12-inch MacBook Air, DigiTimes reports
Subscribe for More Information
06:32 EDTGWREGuidewire to hire 60-80 new staff in 2015/2016
Subscribe for More Information
06:21 EDTAAPLApple upgraded at Credit Suisse
As previously reported, Credit Suisse upgraded Apple to Outperform from Neutral. The firm raised iPhone volume estimates again to 215M units for both FY15/16 and sees $10 EPS power in CY16 based on a solid and sustainable iPhone trends combined with a muted response from Samsung. Additionally, the firm believes excessive net cash levels indicate a new $200B return program should occur. Price target raised to $130 from $110.
06:20 EDTAAPLApple supplier shows 'unbreakable' smartphone with sapphire display, WSJ says
Subscribe for More Information
06:18 EDTAAPLSilicon Valley shuttle drivers looking to unionize, USA Today reports
Subscribe for More Information
06:09 EDTAAPLApple implied volatility of 38 at upper end of index mean range
Subscribe for More Information
06:06 EDTAAPLApple upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
January 12, 2015
16:50 EDTAAPLGartner says worldwide PC shipments in Q4 grew 1%
Subscribe for More Information
16:00 EDTAAPLOptions Update; January 12, 2015
iPath S&P 500 VIX Short-Term Futures up 1.57 to 33.54. Option volume leaders: AAPL TSLA TWTR AMZN AA SIRI RIG FRO C according to Track Data.
12:53 EDTAAPLApple falls, levels to watch
Subscribe for More Information
09:34 EDTAAPLActive equity options trading
Subscribe for More Information
08:21 EDTAAPLApple poised to gain market share, says JMP Securities
Subscribe for More Information
07:49 EDTZGNXZogenix says Relday multi-dose clinical trial to commence in Jan.
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use